Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene

Cell Rep. 2016 Jan 26;14(3):662-677. doi: 10.1016/j.celrep.2015.12.052. Epub 2016 Jan 7.

Abstract

The identification of molecular networks at the system level in mammals is accelerated by next-generation mammalian genetics without crossing, which requires both the efficient production of whole-body biallelic knockout (KO) mice in a single generation and high-performance phenotype analyses. Here, we show that the triple targeting of a single gene using the CRISPR/Cas9 system achieves almost perfect KO efficiency (96%-100%). In addition, we developed a respiration-based fully automated non-invasive sleep phenotyping system, the Snappy Sleep Stager (SSS), for high-performance (95.3% accuracy) sleep/wake staging. Using the triple-target CRISPR and SSS in tandem, we reliably obtained sleep/wake phenotypes, even in double-KO mice. By using this system to comprehensively analyze all of the N-methyl-D-aspartate (NMDA) receptor family members, we found Nr3a as a short-sleeper gene, which is verified by an independent set of triple-target CRISPR. These results demonstrate the application of mammalian reverse genetics without crossing to organism-level systems biology in sleep research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Cas Systems / genetics
  • Electroencephalography
  • Electromyography
  • Female
  • Genotype
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monophenol Monooxygenase / deficiency
  • Monophenol Monooxygenase / genetics
  • Phenotype
  • Receptors, N-Methyl-D-Aspartate / genetics*
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Reverse Genetics*
  • Sleep / physiology*
  • Wakefulness / physiology*

Substances

  • NR3A NMDA receptor
  • Receptors, N-Methyl-D-Aspartate
  • Monophenol Monooxygenase